4D Molecular gets FDA rare pediatric disease status for CF drug
https://seekingalpha.com/news/4057428-4d-molecular-gets-fda-rare-pediatric-disease-status-for-cf-drug?source=feed_sector_healthcare
Jan 23, 2024 - 4D Molecular Therapeutics (FDMT) has received FDA rare pediatric disease designation for its cystic fibrosis drug candidate 4D-710. Read more here.
0
Lynas Rare Earths Limited (LYSCF) Q2 2024 Earnings Call Transcript
https://seekingalpha.com/article/4664244-lynas-rare-earths-limited-lyscf-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Jan 22, 2024 - Lynas Rare Earths Limited (OTCPK:LYSCF) Q2 2024 Results Conference Call January 21, 2024 6:00 PM ETCompany ParticipantsJennifer Parker - VP Corporate...
0
Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug
https://www.zacks.com/stock/news/2212927/mesoblast-meso-up-on-rare-pediatric-disease-tag-for-heart-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212927
Jan 19, 2024 - Mesoblast's (MESO) Revascor (rexlemestrocel-L) gets FDA's Rare Pediatric Disease designation for treating children with congenital heart disease. Shares rise in after-hours trading.
0
NNN REIT: A Rare Dividend/Value Pick
https://seekingalpha.com/article/4663654-nnn-reit-rare-dividendvalue-pick-stock?source=feed_all_articles
Jan 18, 2024 - NNN REIT stands out from the pack due to its profitability, conservative capitalization, and strong liquidity. Click here to see why NNN stock is a Buy.
0
Kubota: This Legendary Japanese Company Has Rarely Been This Cheap
https://seekingalpha.com/article/4661816-kubota-this-legendary-japanese-company-has-rarely-been-this-cheap?source=feed_tag_japan
Jan 08, 2024 - Kubota Corporation is strong in small farming and industrial equipment. Read more to see why we are maintaining our Buy' rating for KUBTF stock.
0
GCOW: Rare Combination Of High Yield And Dividend Growth
https://seekingalpha.com/article/4661265-gcow-rare-combination-of-high-yield-and-dividend-growth?source=feed_tag_etf_portfolio_strategy
Jan 05, 2024 - Discover Pacer Global Cash Cows Dividend ETF, specializing in high cash flow, dividends & attractive valuation, though performance lags. Click here for more.
0
Rare Stock Picks In December 2023 - From 34 Discerning Analysts
https://seekingalpha.com/article/4661020-draft-rare-stock-picks-december-2023-discerning-analysts?source=feed_tag_editors_picks
Jan 04, 2024 - Discover rare investment picks for December 2023 that you might have overlooked from analysts who make less-frequent recommendations. Read more here.
0
Zevra seeks FDA nod for rare disease therapy arimoclomol
https://seekingalpha.com/news/4050701-zevra-stock-gains-nda-filing-arimoclomol?source=feed_sector_healthcare
Dec 27, 2023 - Zevra Therapeutics (ZVRA) has resubmitted a marketing application for its rare disease therapy arimoclomol to treat Niemann-Pick disease type C. Read more here.
0
Ramaco Resources: The True Rare Pair Trade For 2024
https://seekingalpha.com/article/4659507-ramaco-resources-the-true-rare-pair-trade-for-2024?source=feed_tag_editors_picks
Dec 24, 2023 - I am proposing a pair trade in two classes of stock of Ramaco Resources, with a potential return of 23%-29% without taking market directional exposure. Click here to read more.
0
Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU
https://www.zacks.com/stock/news/2199443/biogen-s-biib-rare-disease-drug-skyclarys-gets-chmp-nod-in-eu?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199443
Dec 18, 2023 - Biogen (BIIB) gets positive CHMP opinion recommending marketing authorization to Skyclarys in the EU for the treatment of Friedreich's ataxia in patients aged 16 years and older.
0